Yüksel Ürün, Professor of Medical Oncology at Ankara University School of Medicine, shared on X:
“BioNTech is stopping its colorectal cancer trial for futility, while other mRNA cancer vaccine programs continue.
BioNTech’s colorectal result and Moderna’s melanoma data remind us of a basic rule: evidence belongs to the population studied. Different cancer. Different setting. Different patients. Different result.”
Other articles featuring Yüksel Ürün on OncoDaily.